Fabien Lamoureux

Summary

Affiliation: CHU Rouen
Location: Rouen, France
Summary:
Analytical and forensic Pharmacology and Toxicology
Pharmacogenetics
Pharmacokinetics
Grants:
PharmD in 2008
PhD in 2012
MSc in 2008
Publications:
PUBMED list:

Publications

  1. Lamoureux F, Duflot T, Woillard J, Metsu D, Pereira T, Compagnon P, et al. Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections. Int J Antimicrob Agents. 2016;47:124-31 pubmed publisher
    ..CYP2C19 genotyping appears useful to guide VCZ initial dosing when coupled with TDM and to explain subtherapeutic concentrations frequently observed in clinical practice. ..
  2. Lamoureux F, Duflot T. Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx). Therapie. 2017;72:257-267 pubmed publisher

Detail Information

Publications2